ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan must bend its strict rules to speed up coronavirus vaccine

It makes little sense to have clinical trials here when lives are at stake

| Japan

Philip Carrigan is the Tokyo-based founder and CEO of Morunda, an executive search business focused on the pharmaceutical and medical device sector.

Scientists all over the world are flouting lockdown laws as they work day and night in hope of finding a coronavirus vaccine. In Japan, companies like AnGes MG and Fujifilm Holdings are working tirelessly to develop COVID-19 treatment options. Despite their diligent efforts, many believe it will be 2021 before treatments or vaccinations are available to the general population.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more